<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04610840</url>
  </required_header>
  <id_info>
    <org_study_id>03/20-Ð½</org_study_id>
    <nct_id>NCT04610840</nct_id>
  </id_info>
  <brief_title>The Use of Direct Puncture Technique With Mini-PCNL</brief_title>
  <official_title>Single-center Randomized Study to Evaluate the Safety and Effectiveness of Direct Puncture of the Caliceal System in Minipercutaneous Nephrolithotripsy (Mini-PCNL)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Petersburg State Pavlov Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Petersburg State Pavlov Medical University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      -  A single-center randomized study to evaluate the safety and effectiveness of direct&#xD;
           puncture of the caliceal system in mini-percutaneous nephrolithotripsy.&#xD;
&#xD;
        -  60 patients&#xD;
&#xD;
        -  Inclusion criteria:&#xD;
&#xD;
             1. all patients aged 18 to 70 years who are planning mini-PCNL, ready to consent to&#xD;
                the study&#xD;
&#xD;
             2. ASA scale 1-3&#xD;
&#xD;
             3. Solitary stone up to 2.5 cm&#xD;
&#xD;
             4. Single access to the caliceal system&#xD;
&#xD;
        -  Exclusion criteria:&#xD;
&#xD;
             1. Active infectious process&#xD;
&#xD;
             2. Coagulopathies&#xD;
&#xD;
             3. Abnormalities of the urinary system&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All patients will be randomized into 2 groups:&#xD;
&#xD;
      Direct puncture - patients who underwent directive puncture under ultrasound or Rg control.&#xD;
      The number of patients is 30 people.&#xD;
&#xD;
      Non-direct puncture - patients who underwent a PCS puncture with retrograde contrast. The&#xD;
      number of patients is 30 people.&#xD;
&#xD;
      Patients will be assigned a randomization number that matches their treatment. Block&#xD;
      randomization using 10 blocks will be performed by a central randomization organization&#xD;
      (www.randomize.net) using a computerized algorithm.&#xD;
&#xD;
      Primary assessed indicators:&#xD;
&#xD;
        1. Gender&#xD;
&#xD;
        2. Age&#xD;
&#xD;
        3. Body mass index&#xD;
&#xD;
        4. Localization of the stone (side, pelvis, upper anterior cup, upper posterior cup, middle&#xD;
           anterior cup, middle posterior cup, lower anterior cup, lower posterior cup)&#xD;
&#xD;
        5. Density of the stone&#xD;
&#xD;
        6. The presence of hydronephrosis&#xD;
&#xD;
      Indicators assessed during the operation - will be assessed by the physician-researcher:&#xD;
&#xD;
        1. Installation of the ureteral catheter&#xD;
&#xD;
        2. Duration of puncture&#xD;
&#xD;
        3. Puncture method (ultrasound, X-ray)&#xD;
&#xD;
        4. The success of the insertion of a flexible guidewire into the calyceal system&#xD;
&#xD;
        5. Problems during dilation of the puncture course&#xD;
&#xD;
        6. Visualization (Excellent, Moderate, Poor)&#xD;
&#xD;
        7. Type of drainage (stent, nephrostomic tube) at the end of the operation Using the Visual&#xD;
           Analogue Pain Scale (VAS), pain assessment is planned at 2 hours, 6 hours, 12 hours and&#xD;
           24 hours after surgery.&#xD;
&#xD;
      In the postoperative period, the patient independently controls the intake of analgesics from&#xD;
      the NSAID group (ketorolac 100 mg) (Patient-controlled analgesia). If the patient requires&#xD;
      analgesics, the time of taking the drug will be recorded (pain relief on demand).&#xD;
&#xD;
      Secondary Assessment: Postoperative Assessment&#xD;
&#xD;
        1. Complications (Clavien)&#xD;
&#xD;
        2. Hemoglobin level 24 hours after surgery&#xD;
&#xD;
        3. Creatinine level 24 hours after surgery&#xD;
&#xD;
        4. Assessment of Stone-Free status after surgery by performing multislice computed&#xD;
           tomography of the kidneys and urinary tract without intravenous contrast&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 1, 2020</start_date>
  <completion_date type="Anticipated">April 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">February 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Puncture duration</measure>
    <time_frame>during the operation (mini-PCNL)</time_frame>
    <description>Measurement of puncture duration (in seconds)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of patients with successful direct puncture</measure>
    <time_frame>during the operation (mini-PCNL)</time_frame>
    <description>Evaluation of efficacy</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Purity of a visual intraoperative field</measure>
    <time_frame>during the operation (mini-PCNL)</time_frame>
    <description>Excellent, Moderate, Poor visualization</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Body pain</measure>
    <time_frame>24 hours after operation</time_frame>
    <description>Using the Visual Analogue Pain Scale (VAS), pain assessment is planned at 2 hours, 6 hours, 12 hours and 24 hours after surgery</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Urolithiasis</condition>
  <arm_group>
    <arm_group_label>Direct puncture</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Direct puncture of the caliceal system performed under ultrasound or Xray control</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-direct puncture</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Puncture of the caliceal system performed under ultrasound or Xray control and retrograde contrast</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Puncture of the caliceal system</intervention_name>
    <description>Puncture of the caliceal system under ultrasound/Xray control</description>
    <arm_group_label>Direct puncture</arm_group_label>
    <arm_group_label>Non-direct puncture</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients aged 18 to 70 years who are scheduled for mini-PCNL, ready to consent to the&#xD;
             study&#xD;
&#xD;
          -  ASA scale 1-3&#xD;
&#xD;
          -  Solitary kidney stone up to 2.5 cm&#xD;
&#xD;
          -  One access to the caliceal system&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Active infectious process&#xD;
&#xD;
          -  Coagulopathies&#xD;
&#xD;
          -  Abnormalities of the urinary system&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Dmitry S Gorelov</last_name>
    <phone>+79217964892</phone>
    <email>dsgorelov@mail.ru</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Vladimir M Obidniak</last_name>
    <phone>+79218944746</phone>
    <email>v.obidniak@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>First Pavlov Saint Petersburg University</name>
      <address>
        <city>Saint Petersburg</city>
        <zip>197342</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dmitriy Gorelov, MD</last_name>
      <phone>+79217964892</phone>
      <email>dsgorelov@mail.ru</email>
    </contact>
  </location>
  <location_countries>
    <country>Russian Federation</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>August 5, 2020</study_first_submitted>
  <study_first_submitted_qc>October 26, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 2, 2020</study_first_posted>
  <last_update_submitted>November 8, 2021</last_update_submitted>
  <last_update_submitted_qc>November 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>urolithiasis</keyword>
  <keyword>PCNL</keyword>
  <keyword>direct puncture</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urolithiasis</mesh_term>
    <mesh_term>Urinary Calculi</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

